Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders
Citation: Molecular and Cellular Pediatrics 2015 2(Suppl 1):A1
Volume 2 Supplement 1
This supplement has not been sponsored.
51st Workshop for Pediatric Research.
Göttingen, Germany16-17 April 2015